Name:
Synovial Cell Sarcoma
Other Name(s):
Acronym(s):
Severity:
Genetic:
Idiopathic:
Predisposed Breeds:
Onset Age:
Overview
Synovial cell sarcoma (SCS), often called synovial sarcoma, is an uncommon tumor that accounts for a small fraction of soft tissue sarcomas in dogs. Originating from the synovial tissues of joints, tendons, or sheaths, it predominantly affects the limbs. This malignant condition is aggressive and requires swift action for effective treatment. Its severity lies in its potential to metastasize.
Causes
The exact cause of SCS remains elusive. Genetic mutations are believed to play a significant role in its development. However, the specific genetic changes responsible for this cancer are not well understood.
While there are no established secondary causes, some experts suggest that chronic inflammation or past joint injuries may contribute to the condition. These factors could increase the risk of developing SCS.
Environmental and hereditary influences may also be involved, although their exact affect is unclear. Further research is needed to identify specific environmental or genetic factors that could predispose dogs to SCS.
Predisposed Breeds
Breeds predisposed to synovial cell sarcoma include:
Symptoms
Primary symptoms of SCS include lameness, noticeable swelling around the joint, and pain. These symptoms can significantly reduce a dog’s mobility and overall quality of life.
Secondary symptoms may emerge as the condition progresses. Dogs may show decreased appetite, lethargy, and weight loss, which can further affect their health and well-being.
Sometimes, other symptoms, like visible masses near the joints, can be seen. In advanced stages, metastasis to the lungs or lymph nodes may occur, complicating the condition.
Synovial cell sarcoma symptoms include:
- Lameness
- Swelling around the affected joint
- Pain
- Decreased appetite
- Lethargy
- Weight loss
- Visible masses near joints
Diagnosis
Diagnosing SCS involves a combination of clinical and physical examinations. Veterinarians often use imaging techniques like X-rays or MRI to assess the extent of the tumor in the affected joint.
A biopsy of the suspicious tissue is important for confirming malignancy. This step helps differentiate SCS from other conditions with similar clinical signs, such as fibrosarcoma, osteosarcoma, and septic arthritis.
Correct diagnosis is essential for determining the appropriate treatment plan. It makes sure the chosen therapeutic approach targets the specific nature of SCS effectively.
Treatment
The primary treatment for SCS is surgical removal of the tumor. This approach excises as much of the cancerous tissue as possible to prevent further spread.
Following surgery, veterinarians may recommend radiation therapy or chemotherapy. These treatments help target any remaining cancerous cells, reducing the risk of recurrence and improving long-term outcomes.
Management
Post-treatment management of SCS focuses on regular veterinary check-ups. These visits are essential for monitoring the dog’s condition and detecting any signs of recurrence promptly.
Pain management plays an important role in maintaining the dog’s quality of life. Veterinarians may prescribe medications to alleviate discomfort and ensure the dog remains comfortable during the recovery process.
Prevention
While specific preventive measures for SCS are not available, maintaining overall joint health is important. Regular exercise and a balanced diet contribute to the dog’s overall well-being and joint function.
Routine veterinary visits are essential for early detection. Regular check-ups let veterinarians identify potential issues before they develop into more severe conditions, enabling timely intervention.
